About Novartis Oncology
research, innovation, oncology, hematology, immunooncology, quality, pharmaceutical manufacturing, hospital & health care, pharmaceuticals, medical
Decision Makers at Novartis Oncology
1 contactIvanna Ratner
Director, IM US Product Strategy P&OBP
Unlock full contact details including verified emails and LinkedIn profiles
Upgrade to ProSales Outreach Angle
Novartis Oncology. Use StackWho to identify the right decision-maker email for targeted sales outreach, recruiting, or partnership development.
Novartis Oncology's Position in the StackWho Database
- • Novartis Oncology is 1 of 2,188 pharmaceuticals companies tracked in StackWho.
- • 2,175 pharmaceuticals companies in our database have verified decision-maker emails (99% of the cohort).
- • 380 companies in Basel-Stadt are in the StackWho database.
- • 193 pharmaceuticals companies are in the 1001-5000 employee range (same size as Novartis Oncology).
Technology detection from public web signals. Decision-maker contacts compiled from LinkedIn public profiles, company filings, and verified outbound testing. Methodology & sources · Updated July 2026.
Frequently Asked Questions
What technology does Novartis Oncology use?
Full technology stack data for Novartis Oncology is available on StackWho.
How do I contact the decision makers at Novartis Oncology?
StackWho has verified email addresses for 1 decision maker at Novartis Oncology. Pro members can access direct emails for the CEO, CTO, VP of Engineering, and other key contacts. Use StackWho to reach Novartis Oncology directly for sales, recruiting, or partnerships.
What industry is Novartis Oncology in?
Novartis Oncology operates in the pharmaceuticals industry, headquartered in Basel, Basel-Stadt, Switzerland. StackWho tracks technology stacks and decision maker contacts for companies across all industries.
Similar pharmaceuticals Companies
View allAstraZeneca
astrazeneca.com
Sanofi
sanofi.com
Pfizer
pfizer.com
Novo Nordisk
novonordisk.com
Decision Makers
Ivanna Ratner
Director, IM US Product Strategy P&OBP